Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Completed
Conditions studied: Obstructive Sleep Apnea Syndrome, Polycystic Ovary Syndrome, Sleep Apnea
In brief
Polycystic ovary syndrome (PCOS) is one of the most common disease caused by hormonal imbalance and is also associated with overweight and obesity. It affects 5-10% of adolescent girls and women capable of having children. Polycystic ovary syndrome is associated with missed menstrual periods, hormonal imbalance, being overweight, and with a form of diabetes. Girls with polycystic ovary syndrome may have a breathing problem known as "sleep apnea." Sleep apnea may cause a person to stop breathing for short periods of time while sleeping. People with polycystic ovary syndrome are thirty times more likely to develop sleep apnea than those who do not have PCOS. If sleep apnea is not treated, it may lead to daytime sleepiness, poor school performance, high blood pressure, heart disease and diabetes. The purpose of this study is to understand how insulin function is affected in presence of sleep apnea in girls with polycystic ovary syndrome between 13-21 years of age as compared to girls with PCOS without sleep apnea. Insulin is one of the hormones made in your body to convert food into energy. In people with increase weight body cannot use insulin properly. The investigators also want to see if insulin action is also affected by sleep apnea.
Key facts
- Study ID
- NCT01840618
- Run by
- Albert Einstein College of Medicine
- People needed
- 50
- Starts
- 2012-02-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2019-08-28
Who can join
Age: 13 and older, up to 21. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Female.
- Ages 13-21
- PCOS
- BMI >95%ile (Obese group) or <85%ile (Lean group)
- Controls: ages 18-21, regular menses, BMI <85%ile
You may not qualify if…
- Breastfeeding.
- Pregnant.
- Use of any steroid preparations (including hormonal contraception), medications known to alter insulin secretion and/or action within 3 month (including Metformin)
Where it is running
- Children's Hospital at Montefiore — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.